Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

TCS Holding is preparing a new dividend policy

5/24/24 T

Moscow Exchange looks closely at Asian markets

5/24/24 MOEX

Moscow Exchange will develop grain trading

5/23/24 MOEX

Shareholders of Henderson approved dividends for 3 months 2024

5/23/24 HNFG

Shareholders of Inter RAO approved dividends for 2023

5/23/24 IRAO

Rostelecom to abandon Oracle systems

5/23/24 RTKM

VK reports for the first quarter of 2024

5/23/24 VKCO

Norilsk Nickel will not pay dividends for 2023

5/23/24 GMKN

Board of Directors of Sovcombank recommended that dividends be paid for 2023

5/23/24 SVCB

Cyprus broker ready to buy 20% stake in CYAN

5/23/24 CIAN